@Hadrian
The key point is that the very purpose of generics is to circumvent the high prices of branded product, which are caused by the dysfunctional incentives of the middle-men. So what sense would it make to have them held hostage to those channels? More to the point, what incentive would those middle-men have to push low priced generics?
@HadrianThe key point is that the very purpose of generics is to...
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.5¢ |
Change
-0.001(1.52%) |
Mkt cap ! $19.18M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.6¢ | 6.5¢ | $11.08K | 170.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 181140 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 180000 | 1 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.5¢ |
Change
-0.001 ( 2.99 %) |
||||
| Open | High | Low | Volume | ||
| 6.5¢ | 6.5¢ | 6.5¢ | 14336 | ||
| Last updated 15.27pm 28/05/2024 ? | |||||
| ACR (ASX) Chart |